{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:56:48Z","timestamp":1784915808348,"version":"3.55.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11154-018-9476-x","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T22:24:00Z","timestamp":1543875840000},"page":"355-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The protective effect of myo-inositol on human thyrocytes"],"prefix":"10.1007","volume":"19","author":[{"given":"Silvia Martina","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ragusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Rosaria","family":"Paparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poupak","family":"Fallahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"9476_CR1","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1210\/jc.2013-2409","volume":"99","author":"A Garmendia Madiaraga","year":"2014","unstructured":"Garmendia Madiaraga A, Santos Palacios S, Guill\u00e9n-Grima F, Galofr\u00e9 JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99:923\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"9476_CR2","doi-asserted-by":"crossref","unstructured":"Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489\u201399.","DOI":"10.1210\/jcem.87.2.8182"},{"key":"9476_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1089\/thy.2007.0234","volume":"18","author":"S Benvenga","year":"2008","unstructured":"Benvenga S, Trimarchi F. Changed presentation of Hashimoto's thyroiditis in north-eastern Sicily and Calabria (southern Italy) based on a 31-year experience. Thyroid. 2008;18:429\u201341.","journal-title":"Thyroid"},{"key":"9476_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055450","volume":"8","author":"A Latina","year":"2013","unstructured":"Latina A, Gullo D, Trimarchi F, Benvenga S. Hashimoto's thyroiditis: similar and dissimilar characteristics in neighboring areas. Possible implications for the epidemiology of thyroid cancer. PLoS One. 2013;8:e55450.","journal-title":"PLoS One"},{"key":"9476_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ando.2010.06.006","volume":"71","author":"M Rizzo","year":"2010","unstructured":"Rizzo M, Rossi RT, Bonaffini O, Scisca C, Altavilla G, Calbo L, et al. Increased annual frequency of Hashimoto's thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. Ann Endocrinol (Paris). 2010;71:525\u201334.","journal-title":"Ann Endocrinol (Paris)"},{"key":"9476_CR6","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s12020-014-0399-3","volume":"48","author":"H Baser","year":"2015","unstructured":"Baser H, Can U, Baser S, Yerlikaya FH, Aslan U, Hidayetoglu BT. Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis. Endocrine. 2015;48:916\u201323.","journal-title":"Endocrine"},{"key":"9476_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.clinbiochem.2012.11.021","volume":"46","author":"R Rostami","year":"2013","unstructured":"Rostami R, Aghasi MR, Mohammadi A, Nourooz-Zadeh J. Enhanced oxidative stress in Hashimoto's thyroiditis: inter-relationships to biomarkers of thyroid function. Clin Biochem. 2013;46:308\u201312.","journal-title":"Clin Biochem"},{"key":"9476_CR8","doi-asserted-by":"crossref","unstructured":"Ademo\u011flu E, Ozbey N, Erbil Y, Tanrikulu S, Barbaros U, Yanik BT, et al. Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease. Eur J Intern Med. 2006;17:545\u201350.","DOI":"10.1016\/j.ejim.2006.04.013"},{"key":"9476_CR9","first-page":"696","volume":"60","author":"XL Tang","year":"2005","unstructured":"Tang XL, Liu XJ, Sun WM, Zhao J, Zheng RL. Oxidative stress in Graves' disease patients and antioxidant protection against lymphocytes DNA damage in vitro. Pharmazie. 2005;60:696\u2013700.","journal-title":"Pharmazie"},{"key":"9476_CR10","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1210\/jc.2007-0660","volume":"92","author":"Y Song","year":"2007","unstructured":"Song Y, Driessens N, Costa M, De Deken X, Detours V, Corvilain B, et al. Roles of hydrogen peroxide in thyroid physiology and disease. J Clin Endocrinol Metab. 2007;92:3764\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"9476_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1677\/joe.0.1560315","volume":"156","author":"C Riou","year":"1998","unstructured":"Riou C, Remy C, Rabilloud R, Rousset B, Fonlupt P. H2O2 induces apoptosis of pig thyrocytes in culture. J Endocrinol. 1998;156:315\u201322.","journal-title":"J Endocrinol"},{"key":"9476_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/01.HYP.0000123070.31763.55","volume":"43","author":"DN Granger","year":"2004","unstructured":"Granger DN, Vowinkel T, Petnehazy T. Modulation of the inflammatory response in cardiovascular disease. Hypertension. 2004;43:924\u201331.","journal-title":"Hypertension"},{"key":"9476_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3892\/ijmm.2012.1102","volume":"30","author":"T Kiyoshima","year":"2012","unstructured":"Kiyoshima T, Enoki N, Kobayashi I, Sakai T, Nagata K, Wada H, et al. Oxidative stress caused by a low concentration of hydrogen peroxide induces senescence-like changes in mouse gingival fibroblasts. Int J Mol Med. 2012;30:1007\u201312.","journal-title":"Int J Mol Med"},{"key":"9476_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1600-0765.1993.tb01069.x","volume":"28","author":"S Kimura","year":"1993","unstructured":"Kimura S, Yonemura T, Kaya H. Increased oxidative product formation by peripheral blood polymorphonuclear leukocytes in human periodontal diseases. J Periodontal Res. 1993;28:197\u2013203.","journal-title":"J Periodontal Res"},{"key":"9476_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1051\/vetres:2002047","volume":"33","author":"E Chiaradia","year":"2002","unstructured":"Chiaradia E, Gaiti A, Scaringi L, Cornacchione P, Marconi P, Avellini L. Antioxidant systems and lymphocyte proliferation in the horse, sheep and dog. Vet Res. 2002;33:661\u20138.","journal-title":"Vet Res"},{"key":"9476_CR16","doi-asserted-by":"publisher","first-page":"9060","DOI":"10.1523\/JNEUROSCI.17-23-09060.1997","volume":"17","author":"S Desagher","year":"1997","unstructured":"Desagher S, Glowinski J, Pr\u00e9mont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci. 1997;17:9060\u20137.","journal-title":"J Neurosci"},{"key":"9476_CR17","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1242\/jcs.02507","volume":"118","author":"D Zhu","year":"2005","unstructured":"Zhu D, Tan KS, Zhang X, Sun AY, Sun GY, Lee JC. Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes. J Cell Sci. 2005;118:3695\u2013703.","journal-title":"J Cell Sci"},{"key":"9476_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s12031-015-0680-9","volume":"58","author":"N Nakayama","year":"2016","unstructured":"Nakayama N, Yamaguchi S, Sasaki Y, Chikuma T. Hydrogen peroxide-induced oxidative stress activates proteasomal trypsin-like activity in human U373 glioma cells. J Mol Neurosci. 2016;58:297\u2013305.","journal-title":"J Mol Neurosci"},{"key":"9476_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/jcp.1041490302","volume":"149","author":"DR Janero","year":"1991","unstructured":"Janero DR, Hreniuk D, Sharif HM. Hydrogen peroxide-induced oxidative stress to the mammalian heart-muscle cell (cardiomyocyte): lethal peroxidative membrane injury. J Cell Physiol. 1991;149:347\u201364.","journal-title":"J Cell Physiol"},{"key":"9476_CR20","doi-asserted-by":"crossref","unstructured":"Benhamou PY, Moriscot C, Richard MJ, Beatrix O, Badet L, Pattou F, et al. Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia. 1998;41:1093\u2013100.","DOI":"10.1007\/s001250051035"},{"key":"9476_CR21","doi-asserted-by":"publisher","first-page":"27905","DOI":"10.1074\/jbc.274.39.27905","volume":"274","author":"P Maechler","year":"1999","unstructured":"Maechler P, Jornot L, Wollheim CB. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J Biol Chem. 1999;274:27905\u201313.","journal-title":"J Biol Chem"},{"key":"9476_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbrc.2014.05.143","volume":"450","author":"N Pierre","year":"2014","unstructured":"Pierre N, Barb\u00e9 C, Gilson H, Deldicque L, Raymackers JM, Francaux M. Activation of ER stress by hydrogen peroxide in C2C12 myotubes. Biochem Biophys Res Commun. 2014;450:459\u201363.","journal-title":"Biochem Biophys Res Commun"},{"key":"9476_CR23","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.freeradbiomed.2010.01.022","volume":"48","author":"P Kaczara","year":"2010","unstructured":"Kaczara P, Sarna T, Burke JM. Dynamics of H2O2 availability to ARPE-19 cultures in models of oxidative stress. Free Radic Biol Med. 2010;48:1064\u201370.","journal-title":"Free Radic Biol Med"},{"key":"9476_CR24","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.7150\/ijms.8356","volume":"11","author":"KB Choo","year":"2014","unstructured":"Choo KB, Tai L, Hymavathee KS, Wong CY, Nguyen PN, Huang CJ, et al. Oxidative stress-induced premature senescence in Wharton's jelly-derived mesenchymal stem cells. Int J Med Sci. 2014;11:1201\u20137.","journal-title":"Int J Med Sci"},{"key":"9476_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.12750\/JET.2015.30.4.289","volume":"30","author":"GY Do","year":"2016","unstructured":"Do GY, Kim JW, Chae SK, Ahn JH, Park HJ, Park JY, et al. Antioxidant effect of edaravone on the development of preimplantation porcine embryos against hydrogen peroxide-induced oxidative stress. J Embryo Transfer. 2016;30:289\u201398.","journal-title":"J Embryo Transfer"},{"key":"9476_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/MED.0b013e3282ef1c48","volume":"14","author":"F Guarneri","year":"2007","unstructured":"Guarneri F, Benvenga S. Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr Opin Endocrinol Diabetes Obes. 2007;14:398\u2013409.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"9476_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174\u201380.","journal-title":"Autoimmun Rev"},{"key":"9476_CR28","doi-asserted-by":"publisher","first-page":"468107","DOI":"10.1155\/2012\/468107","volume":"2012","author":"P Fallahi","year":"2012","unstructured":"Fallahi P, Ferri C, Ferrari SM, Corrado A, Sansonno D, Antonelli A. Cytokines and HCV-related disorders. Clin Dev Immunol. 2012;2012:468107.","journal-title":"Clin Dev Immunol"},{"key":"9476_CR29","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1073\/pnas.84.9.2868","volume":"84","author":"AD Luster","year":"1987","unstructured":"Luster AD, Jhanwar SC, Chaganti RS, Kersey JH, Ravetch JV. Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells. Proc Natl Acad Sci U S A. 1987;84:2868\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9476_CR30","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1084\/jem.182.5.1301","volume":"182","author":"F Liao","year":"1995","unstructured":"Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM. Human Mig chemokine: biochemical and functional characterization. J Exp Med. 1995;182:1301\u201314.","journal-title":"J Exp Med"},{"key":"9476_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jlb.61.3.246","volume":"61","author":"JM Farber","year":"1997","unstructured":"Farber JM. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol. 1997;61:246\u201357.","journal-title":"J Leukoc Biol"},{"key":"9476_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","volume":"13","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13:272\u201380.","journal-title":"Autoimmun Rev"},{"key":"9476_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cytogfr.2014.01.006","volume":"25","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Ferrari SM, Corrado A, Ferrannini E, Fallahi P. CXCR3, CXCL10 and type 1 diabetes. Cytokine Growth Factor Rev. 2014;25:57\u201365.","journal-title":"Cytokine Growth Factor Rev"},{"key":"9476_CR34","doi-asserted-by":"crossref","unstructured":"Antonelli A, Ferrari SM, Fallahi P, Ghiri E, Crescioli C, Romagnani P, et al. Interferon-alpha, \u2212beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists. Cytokine. 2010;50:260\u20137.","DOI":"10.1016\/j.cyto.2010.01.009"},{"key":"9476_CR35","doi-asserted-by":"crossref","unstructured":"Antonelli A, Ferrari SM, Frascerra S, Pupilli C, Mancusi C, Metelli MR, et al. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes. J Clin Endocrinol Metab. 2010;95:E413\u201320.","DOI":"10.1210\/jc.2010-0923"},{"key":"9476_CR36","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1210\/jc.2010-2905","volume":"96","author":"A Antonelli","year":"2011","unstructured":"Antonelli A, Ferrari SM, Frascerra S, Di Domenicantonio A, Nicolini A, Ferrari P, et al. Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab. 2011;96:1859\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"9476_CR37","unstructured":"Antonelli A, Fallahi P, Delle Sedie A, Ferrari SM, Maccheroni M, Bombardieri S, et al. High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis. Clin Exp Rheumatol. 2009;27:22\u20137."},{"key":"9476_CR38","doi-asserted-by":"crossref","unstructured":"Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Sebastiani M, et al. High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. Cytokine. 2008;42:137\u201343.","DOI":"10.1016\/j.cyto.2008.01.002"},{"key":"9476_CR39","doi-asserted-by":"crossref","unstructured":"Antonelli A, Ferrari SM, Frascerra S, Galetta F, Franzoni F, Corrado A, et al. Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10. Cytokine. 2011;55:288\u201393.","DOI":"10.1016\/j.cyto.2011.04.022"},{"key":"9476_CR40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s12020-014-0477-6","volume":"48","author":"LH Duntas","year":"2015","unstructured":"Duntas LH, Benvenga S. Selenium: an element for life. Endocrine. 2015;48:756\u201375.","journal-title":"Endocrine"},{"key":"9476_CR41","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1210\/jcem.87.4.8421","volume":"87","author":"R G\u00e4rtner","year":"2002","unstructured":"G\u00e4rtner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab. 2002;87:1687\u201391.","journal-title":"J Clin Endocrinol Metab"},{"key":"9476_CR42","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1210\/jc.2006-1821","volume":"92","author":"R Negro","year":"2007","unstructured":"Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab. 2007;92:1263\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"9476_CR43","doi-asserted-by":"crossref","unstructured":"Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W, European Group on Graves' Orbitopathy. Selenium and the course of mild Graves' orbitopathy. N Engl J Med 2011;364:1920\u201331.","DOI":"10.1056\/NEJMoa1012985"},{"key":"9476_CR44","doi-asserted-by":"publisher","first-page":"424163","DOI":"10.1155\/2013\/424163","volume":"2013","author":"M Nordio","year":"2013","unstructured":"Nordio M, Pajalich R. Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis. J Thyroid Res. 2013;2013:424163.","journal-title":"J Thyroid Res"},{"key":"9476_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1196\/annals.1320.015","volume":"1033","author":"S Benvenga","year":"2004","unstructured":"Benvenga S, Amato A, Calvani M, Trimarchi F. Effects of carnitine on thyroid hormone action. Ann N Y Acad Sci. 2004;1033:158\u201367.","journal-title":"Ann N Y Acad Sci"},{"key":"9476_CR46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.14310\/horm.2002.1494","volume":"13","author":"R Chee","year":"2014","unstructured":"Chee R, Agah R, Vita R, Benvenga S. L-carnitine treatment in a seriously ill cancer patient with severe hyperthyroidism. Hormones (Athens). 2014;13:407\u201312.","journal-title":"Hormones (Athens)"},{"key":"9476_CR47","doi-asserted-by":"crossref","unstructured":"Jiang WD, Hu K, Liu Y, Jiang J, Wu P, Zhao J, et al. Dietary myo-inositol modulates immunity through antioxidant activity and the Nrf2 and E2F4\/cyclin signalling factors in the head kidney and spleen following infection of juvenile fish with Aeromonas hydrophila. Fish Shellfish Immunol. 2016;49:374\u201386.","DOI":"10.1016\/j.fsi.2015.12.017"},{"key":"9476_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1477-7827-12-112","volume":"12","author":"A Agarwal","year":"2014","unstructured":"Agarwal A, Durairajanayagam D, du Plessis SS. Utility of antioxidants during assisted reproductive techniques: an evidence based review. Reprod Biol Endocrinol. 2014;12:112.","journal-title":"Reprod Biol Endocrinol"},{"key":"9476_CR49","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.lfs.2005.05.103","volume":"78","author":"I G\u00fcl\u00e7in","year":"2006","unstructured":"G\u00fcl\u00e7in I. Antioxidant and antiradical activities of L-carnitine. Life Sci. 2006;78:803\u201311.","journal-title":"Life Sci"},{"key":"9476_CR50","unstructured":"World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Bulletin of the World Health Organization. 2001:79."},{"key":"9476_CR51","doi-asserted-by":"crossref","unstructured":"Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Santini E, Franceschini SS, et al. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab. 2009;94:1803\u20139.","DOI":"10.1210\/jc.2008-2450"},{"key":"9476_CR52","doi-asserted-by":"crossref","unstructured":"Antonelli A, Rotondi M, Ferrari SM, Fallahi P, Romagnani P, Franceschini SS, et al. Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab. 2006;91:614\u201320.","DOI":"10.1210\/jc.2005-1689"},{"key":"9476_CR53","doi-asserted-by":"crossref","unstructured":"Marx N, Mach F, Sauty A, Leung JH, Sarafi MN, Ransohoff RM, et al. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol. 2000;164:6503\u20138.","DOI":"10.4049\/jimmunol.164.12.6503"},{"key":"9476_CR54","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.surg.2014.05.005","volume":"156","author":"SM Ferrari","year":"2014","unstructured":"Ferrari SM, Fallahi P, La Motta C, Bocci G, Corrado A, Materazzi G, et al. Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro. Surgery. 2014;156:1167\u201376.","journal-title":"Surgery"},{"key":"9476_CR55","doi-asserted-by":"publisher","first-page":"E572","DOI":"10.1210\/jc.2013-2321","volume":"99","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Bocci G, Fallahi P, La Motta C, Ferrari SM, Mancusi C, et al. CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo. J Clin Endocrinol Metab. 2014;99:E572\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"9476_CR56","doi-asserted-by":"publisher","first-page":"E288","DOI":"10.1210\/jc.2010-1905","volume":"96","author":"A Antonelli","year":"2011","unstructured":"Antonelli A, Bocci G, La Motta C, Ferrari SM, Fallahi P, Fioravanti A, et al. Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. J Clin Endocrinol Metab. 2011;96:E288\u201396.","journal-title":"J Clin Endocrinol Metab"},{"key":"9476_CR57","doi-asserted-by":"crossref","unstructured":"Antonelli A, Ferrari SM, Frascerra S, Corrado A, Pupilli C, Bernini G, et al. Peroxisome proliferator-activated receptor \u03b1 agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease. Exp Cell Res. 2011;317:1527\u201333.","DOI":"10.1016\/j.yexcr.2011.04.007"},{"key":"9476_CR58","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11154-016-9370-3","volume":"17","author":"S Benvenga","year":"2016","unstructured":"Benvenga S, Antonelli A. Inositol(s) in thyroid function, growth and autoimmunity. Rev Endocr Metab Disord. 2016;17:471\u201384.","journal-title":"Rev Endocr Metab Disord"},{"key":"9476_CR59","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1258\/ebm.2009.009241","volume":"235","author":"H Ohye","year":"2010","unstructured":"Ohye H, Sugawara M. Dual oxidase, hydrogen peroxide and thyroid diseases. Exp Biol Med (Maywood). 2010;235:424\u201333.","journal-title":"Exp Biol Med (Maywood)"},{"key":"9476_CR60","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1210\/jc.2007-0366","volume":"92","author":"H Grasberger","year":"2007","unstructured":"Grasberger H, Van Sande J, Hag-Dahood Mahameed A, Tenenbaum-Rakover Y, Refetoff S. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates\/Ca2+ cascade mediates TSH action on thyroid hormone synthesis. J Clin Endocrinol Metab. 2007;92:2816\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"9476_CR61","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1600-065X.2008.00750.x","volume":"228","author":"DA Fruman","year":"2009","unstructured":"Fruman DA, Bismuth G. Fine tuning the immune response with PI3K. Immunol Rev. 2009;228:253\u201372.","journal-title":"Immunol Rev"},{"key":"9476_CR62","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12026-007-0075-2","volume":"39","author":"M Kashiwada","year":"2007","unstructured":"Kashiwada M, Lu P, Rothman PB. PIP3 pathway in regulatory T cells and autoimmunity. Immunol Res. 2007;39:194\u2013224.","journal-title":"Immunol Res"},{"key":"9476_CR63","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1365-2265.1986.tb01658.x","volume":"24","author":"E Martino","year":"1986","unstructured":"Martino E, Macchia E, Aghini-Lombardi F, Antonelli A, Lenziardi M, Concetti R, et al. Is humoral thyroid autoimmunity relevant in amiodarone iodine-induced thyrotoxicosis (AIIT)? Clin Endocrinol. 1986;24:627\u201333.","journal-title":"Clin Endocrinol"},{"key":"9476_CR64","doi-asserted-by":"crossref","unstructured":"Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, Protopapadakis EE, et al. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto\u2019s thyroiditis. Thyroid. 2007;17:609\u201312.","DOI":"10.1089\/thy.2007.0040"},{"key":"9476_CR65","unstructured":"Zhu L, Bai X, Teng WP, Shan ZY, Wang WW, Fan CL, et al. Effects of selenium supplementation on antibodies of autoimmune thyroiditis. Zhonghua Yi Xue Za Zhi. 2012;92:2256\u201360."},{"issue":"Suppl2","key":"9476_CR66","first-page":"51","volume":"21","author":"M Nordio","year":"2017","unstructured":"Nordio M, Basciani S. Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto's patients with subclinical hypothyroidism. Eur Rev Med Pharmacol Sci. 2017;21(Suppl2):51\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"Suppl 2","key":"9476_CR67","first-page":"36","volume":"21","author":"SM Ferrari","year":"2017","unstructured":"Ferrari SM, Fallahi P, Di Bari F, Vita R, Benvenga S, Antonelli A. Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis. Eur Rev Med Pharmacol Sci. 2017;21(Suppl 2):36\u201342.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"9476_CR68","doi-asserted-by":"publisher","first-page":"2549491","DOI":"10.1155\/2017\/2549491","volume":"2017","author":"M Nordio","year":"2017","unstructured":"Nordio M, Basciani S. Treatment with Myo-inositol and selenium ensures Euthyroidism in patients with autoimmune thyroiditis. Int J Endocrinol. 2017;2017:2549491.","journal-title":"Int J Endocrinol"},{"key":"9476_CR69","doi-asserted-by":"crossref","unstructured":"Esposito D, Rotondi M, Accardo G, Vallone G, Conzo G, Docimo G, et al. Influence of short-term selenium supplementation on the natural course of Hashimoto's thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial. J Endocrinol Investig. 2017;40:83\u20139.","DOI":"10.1007\/s40618-016-0535-4"},{"issue":"Suppl 2","key":"9476_CR70","first-page":"89","volume":"21","author":"S Benvenga","year":"2017","unstructured":"Benvenga S, Vicchio T, Di Bari F, Vita R, Fallahi P, Ferrari SM, et al. Favorable effects of myo-inositol, selenomethionine or their combination on the hydrogen peroxide-induced oxidative stress of peripheral mononuclear cells from patients with Hashimoto's thyroiditis: preliminary in vitro studies. Eur Rev Med Pharmacol Sci. 2017;21(Suppl 2):89\u2013101.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-018-9476-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-018-9476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-018-9476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:36:20Z","timestamp":1775291780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-018-9476-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["9476"],"URL":"https:\/\/doi.org\/10.1007\/s11154-018-9476-x","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"4 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}}]}}